Skip to main content
Clinical Trials/NCT00627614
NCT00627614CompletedNot Applicable

Identification and Differentiation of Breast Masses by Vibro-Acoustography

Mayo Clinic1 site in 1 country147 target enrollmentStarted: March 1, 2006Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
147
Locations
1
Primary Endpoint
Detection and differentiation of breast masses with an estimated specificity of ≥ 70% using vibro-acoustography (VA) imaging

Study Overview

Brief Summary

RATIONALE: New diagnostic procedures, such as vibro-acoustography imaging, may be an effective method of diagnosing breast cancer.

PURPOSE: This clinical trial is studying how well vibro-acoustography imaging works in diagnosing breast masses in women with a breast mass or breast cancer.

Detailed Description

OBJECTIVES:

  • To study in vivo detection of breast masses by vibro-acoustography (VA) imaging.
  • To evaluate the performance of VA imaging in differentiating between benign and malignant breast masses identified as BI-RADS 4 or 5.

OUTLINE: Patients undergo clinical mammography of the breast, followed by vibro-acoustography (VA) imaging using ultrasonography over 90 minutes. Patients may also undergo further imaging using clinical ultrasonography.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •DISEASE CHARACTERISTICS:
  • •Suspiciuos breast lesions identified as BI-RADS 4 or 5 and 3
  • •Hormone receptor status not specified
  • •PATIENT CHARACTERISTICS:
  • •Menopausal status not specified
  • •Not pregnant
  • •No condition that does not allow proper use of study imaging devices
  • •PRIOR CONCURRENT THERAPY:
  • •See Disease Characteristics

Exclusion Criteria

  • Not provided

Arms & Interventions

breast imaging study

Experimental

Intervention: breast imaging study (Other)

Outcomes

Primary Outcomes

Detection and differentiation of breast masses with an estimated specificity of ≥ 70% using vibro-acoustography (VA) imaging

Time Frame: 25 minutes for Breast VA imaging

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Azra Alizad

PI

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials